FIELD: chemistry.
SUBSTANCE: invention relates to 7-(4-methoxyphenyl)-5-phenyl-4,5-dihydro-[1,2,4]triazolo [1,5-a]pyrimidine as an activator of glucokinase and an inhibitor of dipeptidyl peptidase of type 4: . The invention also relates to the method of its production.
EFFECT: new compound is produced that can be used as an activator of glucokinase and an inhibitor of dipeptidyl peptidase of type 4.
2 cl, 3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ENANTIOMERS 6-ETHOXYCARBONYL-7-(THIEN-2-YL)-5-METHYL-4,7-DIGYDRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE AND 6-ETHOXYCARBONYL-7-PHENYL-5-METHYL-4,7-DIHYDRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE, WITH TUBERCULOSTATIC ACTIVITY | 2017 |
|
RU2654463C1 |
PYRIDOXINE-BASED COMPOUNDS CAPABLE OF GLUCOKINASE ENZYME ACTIVATION | 2017 |
|
RU2644355C1 |
2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF | 2018 |
|
RU2716715C2 |
BIS[1,2,4]TRIAZOLO[4,3-b:3',4'-f][1,2,4,5]TETRAZINES WITH ANTI-GLYCATING, ANTI-GLYCOXIDATION AND ANTIPLATELET ACTIVITY | 2020 |
|
RU2755897C1 |
2-FURYL-6-NITRO-1,2,4-TRIAZOLO [1,5-A] PYRIMIDINE-7-ONE | 2016 |
|
RU2620594C1 |
METHOD OF PRODUCING 6-ETHOXYCARBONYL-7- (THIEN-2-YL) -5-METHYL-4,7-DIHYDRO-1,2,4-TRIAZOLO [1,5-A]PYRIMIDINE THAT HAS HIGH TUBERCULOSTATIC ACTIVITY | 2017 |
|
RU2642420C1 |
INJECTION OR INFUSION SOLUTION OF L-ARGININE SALT OF 5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a] PYRIMIDIN-7-ONE MONOHYDRATE FOR THERAPY OF INFLUENZA AND OTHER VIRAL INFECTIONS | 2014 |
|
RU2586283C1 |
SELECTIVE ANTITUBERCULOUS AGENTS REPRESENTING SUBSTITUTED 7-ARYL(HETERYL)-6-CARBETHOXY-4,7-DIHYDRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES OR SUBSTITUTED 7-ARYL(HETERYL)-4,7-DIHYDRO-6-NITRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE SALTS, PHARMACEUTICAL COMPOSITION THEREOF AND METHOD FOR PREPARATION OF SUBSTITUTED 7-ARYL(HETERYL)-6-CARBETHOXY-5-METHYL-4,7-DIHYDRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES | 2007 |
|
RU2360905C2 |
SODIUM SALT OF DIETHYL ETHER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID MONOHYDRATE | 2015 |
|
RU2612300C1 |
PHARMACEUTICAL COMPOSITION OF ANTIGLYCATING ACTIVITY IN SOLID DOSAGE FORM IN FORM OF CAPSULES AND METHOD FOR PREPARATION THEREOF | 2019 |
|
RU2738804C1 |
Authors
Dates
2018-01-25—Published
2017-06-19—Filed